Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Hematology · Autosomal Recessive Congenital Sideroblastic Anemia

The Biology and Diagnosis of Autosomal Recessive Sideroblastic Anemia

At a Glance

Autosomal recessive sideroblastic anemia is an inherited disorder in which red blood cells cannot use iron normally to make hemoglobin. Diagnosis combines blood and iron tests with genetic testing; a bone marrow stain may show iron-filled ring sideroblasts.

To understand why your child has Autosomal Recessive Congenital Sideroblastic Anemia (AR-CSA), it helps to look inside the “factory” where red blood cells are made. In children with this condition, the factory is missing a key tool or part, causing iron to pile up like unused raw material [1].

The Biological “Glitch”: How Anemia Happens

Red blood cells need a protein called hemoglobin to carry oxygen. To make hemoglobin, the body must produce heme—the part that actually holds onto iron [2]. This process happens inside the mitochondria, the tiny power plants found in almost every cell [3].

In AR-CSA, genetic mutations break this process in various ways, for example:

  1. Heme Production Failure: Genes like SLC25A38 act as transporters, bringing ingredients (like the amino acid glycine) into the mitochondria to start making heme [2][4]. If the ingredients can’t get in, heme cannot be made.
  2. Iron-Sulfur Cluster Disruption: Genes like GLRX5 and HSPA9 help build “clusters” of iron and sulfur [5][6]. These clusters are like “master switches” that tell the cell how to handle iron. When they are missing, the cell gets confused and keeps pulling in iron even though it can’t use it [7].

This leads to ineffective erythropoiesis—a term doctors use to describe a bone marrow that is working hard to make red blood cells, but those cells are defective and die before they can ever reach the bloodstream [1][8].

What are Ring Sideroblasts?

The name of the condition comes from a specific finding in the bone marrow. When iron enters the mitochondria but cannot be used to make heme, it becomes trapped. These iron-loaded mitochondria cluster in a circle around the cell’s nucleus [3].

When a pathologist uses a special blue stain (called Prussian blue) on a bone marrow sample, these circles look like a blue ring [3]. The cell is called a sideroblast (an immature red blood cell containing iron), and because of the circle, it is specifically called a ring sideroblast [9][10]. Seeing these under a microscope is a hallmark of the disease, though they can also appear in other conditions [3].

Distinguishing AR-CSA from “Look-Alikes”

Because AR-CSA is so rare, it is often mistaken for more common types of anemia. Doctors must carefully rule out these other possibilities:

Condition Why it looks like AR-CSA How doctors tell the difference
Iron Deficiency Both can cause small (microcytic) and pale (hypochromic) cells [11]. In iron deficiency, iron stores are empty. In AR-CSA, iron stores (ferritin) are usually normal or very high [12][13].
Thalassemia Both are inherited and cause microcytic anemia [13]. Doctors use hemoglobin electrophoresis and genetic testing to check for thalassemia-specific gene mutations [14].
Nutritional/Toxic Issues Lead poisoning, copper deficiency, zinc excess, or Vitamin B6 deficiency can “turn on” ring sideroblasts [10][15]. Doctors test the blood for lead levels and check for low copper or high zinc levels [15]. A detailed medication history is also taken [16].
Acquired MDS Both show ring sideroblasts in the bone marrow [3]. MDS is a clonal myeloid neoplasm (a form of marrow cancer). While more common in older adults, pediatric MDS exists and requires specialized genetic testing to differentiate [11][17].

Possible Components of a Diagnostic Evaluation

A diagnosis may involve several tests depending on the presentation. Some cases even remain genetically unresolved [18]. You should review your child’s medical records for the following:

  • Complete Blood Count (CBC): Often shows microcytic (unusually small) and hypochromic (unusually pale) red blood cells, particularly in SLC25A38, though cell size varies by gene [11][19].
  • Iron Panel: Must include ferritin and transferrin saturation (a measure of how much iron is actively being transported) to check for iron overload, which is common in AR-CSA even before any transfusions [12][20].
  • Bone Marrow Aspirate with Prussian Blue: This is a supportive test to see the ring sideroblasts [3][9]. However, if genetic testing yields a clear diagnosis, this invasive procedure may not always be mandatory.
  • Genetic Testing: A “targeted panel” usually looks for mutations in genes like SLC25A38, GLRX5, HSPA9, and TRNT1 [21][8]. (Note: ALAS2 is often on these panels, but it causes an X-linked form of the disease, not autosomal recessive).
  • Environmental Screen: Blood tests and history to ensure the anemia isn’t caused by lead, lack of vitamin B6, medications, or copper/zinc imbalances [10][22].

If a standard genetic panel comes back “negative,” your doctor may suggest more advanced testing, such as whole-exome sequencing (reading the entire coding region of DNA) or checking the mitochondrial DNA, as some rare variants may be missed on basic tests [23][18].

Common questions in this guide

What is autosomal recessive sideroblastic anemia?
Autosomal recessive sideroblastic anemia is an inherited condition in which gene changes disrupt the process that makes heme, the iron-containing part of hemoglobin. As a result, developing red blood cells may not mature properly, and iron can build up inside their mitochondria.
What are ring sideroblasts in a bone marrow report?
Ring sideroblasts are immature red blood cells with iron-filled mitochondria arranged in a ring around the nucleus. A special Prussian blue stain on a bone marrow sample can make these rings visible, although ring sideroblasts can also occur in other conditions.
Which tests are used to diagnose AR-CSA?
Evaluation may include a complete blood count, ferritin and transferrin saturation, environmental testing, genetic testing, and sometimes a bone marrow aspirate with a Prussian blue stain. The exact tests depend on the child's findings, and a clear genetic result may reduce the need for an invasive bone marrow procedure.
Can iron be high in autosomal recessive sideroblastic anemia before transfusions?
Yes. Because developing red blood cells cannot use iron normally to make heme, iron may accumulate in the body even before transfusions have occurred. Ferritin and transferrin saturation help doctors assess this iron overload.
Which genes may be included on an AR-CSA genetic panel?
A targeted panel may include SLC25A38, GLRX5, HSPA9, and TRNT1. ALAS2 may also appear on a panel, but changes in that gene cause an X-linked form of sideroblastic anemia rather than an autosomal recessive form.
What happens if the first genetic panel does not find a cause?
Some cases remain genetically unresolved after standard testing. A doctor may recommend whole-exome sequencing or mitochondrial DNA analysis because these approaches can identify variants that a basic panel may miss.

Get notified when new evidence is published on Autosomal recessive sideroblastic anemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Iron Metabolism in the Disorders of Heme Biosynthesis.

    Ricci A, Di Betto G, Bergamini E, et al.

    Metabolites 2022; (12(9)) doi:10.3390/metabo12090819.

    PMID: 36144223
  2. 2

    Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.

    Lunetti P, Damiano F, De Benedetto G, et al.

    The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.

    PMID: 27476175
  3. 3

    Causes and Pathophysiology of Acquired Sideroblastic Anemia.

    Rodriguez-Sevilla JJ, Calvo X, Arenillas L

    Genes 2022; (13(9)) doi:10.3390/genes13091562.

    PMID: 36140729
  4. 4

    Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.

    Peoc'h K, Nicolas G, Schmitt C, et al.

    Molecular genetics and metabolism 2019; (128(3)):190-197 doi:10.1016/j.ymgme.2019.01.015.

    PMID: 30737140
  5. 5

    Functional Analysis of GLRX5 Mutants Reveals Distinct Functionalities of GLRX5 Protein.

    Liu G, Wang Y, Anderson GJ, et al.

    Journal of cellular biochemistry 2016; (117(1)):207-17 doi:10.1002/jcb.25267.

    PMID: 26100117
  6. 6

    Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.

    Schmitz-Abe K, Ciesielski SJ, Schmidt PJ, et al.

    Blood 2015; (126(25)):2734-8 doi:10.1182/blood-2015-09-659854.

    PMID: 26491070
  7. 7

    GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.

    Daher R, Mansouri A, Martelli A, et al.

    Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.

    PMID: 30660387
  8. 8

    Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients.

    Dongerdiye R, Kedar PS, Saptarshi A, et al.

    Annals of hematology 2024; (103(10)):3987-3998 doi:10.1007/s00277-024-05969-5.

    PMID: 39196378
  9. 9

    Sideroblastic anemia in children: challenges in diagnosis and management in three cases.

    Rekaya S, Ben Fraj I, Hamdi R, et al.

    Annals of hematology 2025; (104(4)):2537-2543 doi:10.1007/s00277-025-06266-5.

    PMID: 40042629
  10. 10

    When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.

    Girard S, Genevieve F, Rault E, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.

    PMID: 35885655
  11. 11

    Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

    Cazzola M, Malcovati L

    Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.

    PMID: 26637696
  12. 12

    Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.

    Uminski K, Houston DS, Hartley JN, et al.

    Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.

    PMID: 32790119
  13. 13

    Rare anemias due to genetic iron metabolism defects.

    Brissot P, Bernard DG, Brissot E, et al.

    Mutation research. Reviews in mutation research 2018; (777()):52-63 doi:10.1016/j.mrrev.2018.06.003.

    PMID: 30115430
  14. 14

    Reticulocyte Hemoglobin Equivalent (Ret-He) Combined with Red Blood Cell Distribution Width Has a Differentially Diagnostic Value for Thalassemias.

    Lian Y, Shi J, Nie N, et al.

    Hemoglobin 2019; (43(4-5)):229-235 doi:10.1080/03630269.2019.1655440.

    PMID: 31476929
  15. 15

    Zinc-Containing Over-The-Counter Product Causing Sideroblastic Anemia and Neutropenia.

    Stagg MP, Miatech J, Majid B, Polala R

    Cureus 2024; (16(5)):e59796 doi:10.7759/cureus.59796.

    PMID: 38846187
  16. 16

    [The 511th case: severe anemia with increased ringed sideroblasts].

    Liu ZW, Chen M, Han B

    Zhonghua nei ke za zhi 2025; (64(9)):906-910 doi:10.3760/cma.j.cn112138-20250616-00348.

    PMID: 40904303
  17. 17

    Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

    Fouquet C, Le Rouzic MA, Leblanc T, et al.

    British journal of haematology 2019; (187(4)):530-542 doi:10.1111/bjh.16100.

    PMID: 31338833
  18. 18

    Three siblings with variable degrees of neuromuscular involvement and congenital sideroblastic anemia: A peculiar phenotype and a surprise genotypic explanation.

    Salam MAE, Salama K, Selim YMM, et al.

    Annals of human genetics 2023; (87(4)):166-173 doi:10.1111/ahg.12505.

    PMID: 36916508
  19. 19

    A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia.

    Cai J, Liu T, Huang Y, et al.

    Frontiers in pediatrics 2024; (12()):1411676 doi:10.3389/fped.2024.1411676.

    PMID: 39281190
  20. 20

    A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia-a case report.

    Liu X, Ma J, Song A, et al.

    Frontiers in medicine 2026; (13()):1838995 doi:10.3389/fmed.2026.1838995.

    PMID: 42338942
  21. 21

    [Clinical features and gene mutation spectrum in children with sideroblastic anemia].

    An WB, An WB, Liu C, et al.

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(10)):1016-1021.

    PMID: 31642437
  22. 22

    Vitamin B6 Deficiency May Not Always Present As Microcytic Hypochromic Anemia.

    Nakao S, Nakaseko C, Ishii T, et al.

    Cureus 2025; (17(6)):e86768 doi:10.7759/cureus.86768.

    PMID: 40718336
  23. 23

    Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting.

    Sharma P, Bhatia P, Singh M, et al.

    The Journal of molecular diagnostics : JMD 2024; (26(5)):430-444 doi:10.1016/j.jmoldx.2024.01.011.

    PMID: 38360212

This page is for informational purposes only and does not constitute medical advice. A pediatric hematologist, genetic counselor, and pathologist should interpret your child's test results with you.